文献速递主动脉疾病

肾下型腹主动脉瘤腔内修复术前血栓负荷对持续性II型内漏及再干预的预测意义

Significance of preoperative thrombus burden in the prediction of a persistent type II and reintervention after infrarenal endovascular aneurysm repair.
PubMed 文献 · J Vasc Surg · 2022-01-05

单中心血管网络连续纳入2009年10月至2017年10月行肾下型EVAR的230例手术,术前CT血管造影按最大瘤囊直径处血栓占比将血栓负荷分为低(<25%)、中(25%-50%)、高(>50%)三组。低血栓负荷组持续性II型内漏发生率显著高于高血栓负荷组(41% vs 4%,OR 15.36 [3.5-67.3],P=.0003),且低血栓负荷合并肠系膜下动脉通畅者风险更高;高血栓负荷与瘤囊更大程度回缩及较低再干预率相关。

要点

  • 低血栓负荷组持续性II型内漏发生率为41%,高血栓负荷组为4%(OR 15.36 [3.5-67.3],P=.0003)。
  • 13例再干预患者中12例(92%)存在持续性II型内漏(OR 43.4 [5.5-242],P=.0003)。
  • 中、高血栓负荷组瘤囊回缩分别达-25%和-27%,低血栓负荷组为-15%(P=.0046和P<.0001)。

核心结论

  • 低血栓负荷与持续性II型内漏发生率升高相关,肠系膜下动脉通畅时尤为明显;高血栓负荷与瘤囊回缩增加和再干预率降低相关。
  • 血栓负荷可被可靠评估,或可用于肾下型EVAR规划中的风险分层。
  • 作者认为,对低血栓负荷者预防性栓塞肠系膜下动脉或腰动脉可能有益。
  • 血栓负荷或可作为设计EVAR术后随访方案的工具。

研究设计与样本

  • 回顾性分析单中心血管网络2009年10月至2017年10月连续行肾下型EVAR的患者,最终纳入230例手术,中位随访43(12-102)个月。
  • 术前CT血管造影评估血栓负荷,定义为最大瘤囊直径处血栓占该水平正交测量管腔直径的百分比,分为低(<25%)、中(25%-50%)、高(>50%)三组。
  • 术后通过CT血管造影或双功能超声进行EVAR随访,II型内漏持续超过1年定义为持续性II型内漏。
  • 采用比值比(OR)和Student t检验判断显著性。

主要发现

  • 研究期间共实施275例EVAR,排除45例:仅髂动脉干预9例、无术前资料7例、放弃1例、随访数据不足1年28例。
  • 低血栓负荷组持续性II型内漏发生率为41%,高血栓负荷组为4%(OR 15.36 [3.5-67.3],P=.0003)。
  • 13例再干预患者中12例(92%)存在持续性II型内漏(OR 43.4 [5.5-242],P=.0003)。
  • 中血栓负荷组和高血栓负荷组瘤囊回缩分别为-25%和-27%,低血栓负荷组为-15%(P=.0046和P<.0001)。
  • 肠系膜下动脉通畅者平均血栓负荷为29%,闭塞者为40%(P<.0001);低血栓负荷合并肠系膜下动脉通畅者较高血栓负荷合并肠系膜下动脉闭塞者更易发生持续性II型内漏(OR 34.1 [1.99-583],P=.015)。

关键数值与推荐

  • 持续性II型内漏定义为术后观察超过1年的II型内漏。
  • 血栓负荷分组:低<25%、中25%-50%、高>50%。
  • 观察者间一致性kappa值为0.89(0.84-0.94),总体不一致率为7%。
  • 各组间年龄、性别、合并症及术前瘤囊直径无显著差异。

临床怎么用

  • 作者认为,低血栓负荷(尤其合并肠系膜下动脉通畅)者持续性II型内漏风险较高,预防性栓塞肠系膜下动脉或腰动脉可能有益。
  • 作者认为,血栓负荷可可靠评估,或可用于肾下型EVAR规划中的风险分层及设计术后随访方案。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Persistent type II endoleak has necessitated prolonged surveillance and is a reason for reintervention after infrarenal endovascular aneurysm repair (EVAR). The aim of this study was to assess the association of thrombus burden (TB) within the aneurysmal sac in the prediction of a persistent type II endoleaks. METHODS: Consecutive patients who underwent infrarenal EVAR from October 2009 to October 2017 in a single vascular network were included. TB was assessed on preoperative computed tomography angiogram and was defined as a percentage of thrombus across the maximal sac diameter in comparison with the luminal diameter measured orthogonally at the same level. Patients were categorized into three groups: low TB (<25%), medium TB (25%-50%), and high TB (>50%). All patients underwent postoperative EVAR surveillance comprising computed tomographic angiography or duplex ultrasound imaging. Type II endoleak observed for more than 1 year was defined as persistent type II endoleak. Odds ratio (OR) and Student's t-test were used to determine significance. RESULTS: Some 275 EVARs were performed in the study period. A total of 45 procedures were excluded because of either iliac-only intervention (n = 9), no preoperative information (n = 7), abandoned (n = 1), or less than 1 year's follow-up data (n = 28). For the 230 procedures included, the median follow-up was 43 (12-102) months. There were no significant differences between the groups for age, gender, and comorbidities nor preoperative sac diameter. There was high interobserver reliability with a kappa value of 0.89 (0.84-0.94) with a total discordance of 7% across the cohorts. Persistent type II endoleak occurred significantly more frequently with reduced TB: 41% of the low TB cohort compared with 4% of the high TB cohort (OR, 15.36 [3.5-67.3]; P = .0003). Reintervention was also significantly more likely to occur in the presence of a persistent type II endoleak compared with its absence; n = 12 of 13 (92%) patients who underwent reintervention had a persistent type II endoleak (OR, 43.4 [5.5-242]; P = .0003). Sac size reduction was significantly greater in medium TB and high TB cohorts when compared with low TB: -25% and -27% vs -15% (P = .0046 and P < .0001). Decreased TB was associated with a significant increase in inferior mesenteric artery (IMA) patency, the mean TB, where the IMA was patent, being 29% compared with 40% where the IMA was occluded P < .0001. When considered together, patients with a low TB and a patent IMA were even more likely to have a persistent type II endoleak when compared with those with a high TB and an occluded IMA (OR, 34.1 [1.99-583]; P = .015). CONCLUSIONS: Low TB is associated with increased rates of persistent type II endoleak, especially in the presence of a patent IMA. High TB is associated with increased sac regression and low reintervention rates. TB can be assessed reliably and could be used for risk stratification in the planning of infrarenal EVAR. Pre-emptive embolization of IMA or lumbar vessels in those with low TB may be beneficial. TB could be a useful tool for designing a post-EVAR surveillance regimen.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Nicholls J, Kirkham EN, Haslam L, et al. Significance of preoperative thrombus burden in the prediction of a persistent type II and reintervention after infrarenal endovascular aneurysm repair. J Vasc Surg. 2022. PMID: 34995721. doi:10.1016/j.jvs.2021.12.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。